Skip to content

Insider · CIK 0001239786

Mark P Frissora

director

Files at BDPT (BIOADAPTIVES, INC.). First filing -, latest -.

Mark P Frissora files SEC Form 4 as director at BDPT (BIOADAPTIVES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Mark P Frissora has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 21 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+15,625$0.00$0155,2657 d ago
Sep 1, 2026BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+35,715$0.00$0139,64040 d ago
Jun 1, 2026BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+4,717$0.00$076,271Jun 3, 2026
May 1, 2026BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+4,808$0.00$071,554May 5, 2026
Apr 1, 2026BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+4,386$0.00$066,746Apr 3, 2026
Mar 1, 2026BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+2,578$0.00$062,360Mar 3, 2026
Feb 1, 2026BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+2,565$0.00$059,779Feb 3, 2026
Jan 1, 2026BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+2,286$0.00$057,217Jan 5, 2026
Dec 1, 2025BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+2,025$0.00$054,931Dec 3, 2025
Nov 1, 2025BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+1,382$0.00$052,906Nov 4, 2025
Oct 1, 2025BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+1,517$0.00$051,524Oct 6, 2025
Sep 1, 2025BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+1,506$0.00$050,007Sep 3, 2025
Aug 1, 2025BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+1,307$0.00$048,501Aug 5, 2025
Jul 1, 2025BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+847$0.00$047,194Jul 3, 2025
Jun 1, 2025BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+713$0.00$046,347Jun 3, 2025
May 1, 2025BDPT
BIOADAPTIVES, INC.
JOther
Series D Convertible Preferred Stockderivative
+694$0.00$045,634May 23, 2025
Feb 15, 2025BDPT
BIOADAPTIVES, INC.
AGrant or award
Series D Convertible Preferred Stockderivative
+455$11.00$5,0054,092May 5, 2025
Mar 15, 2025BDPT
BIOADAPTIVES, INC.
AGrant or award
Series D Convertible Preferred Stockderivative
+479$10.45$5,0064,571May 5, 2025
Apr 9, 2025BDPT
BIOADAPTIVES, INC.
POpen-market purchase
Series D Convertible Preferred Stockderivative
+39,868$7.52$300k44,439May 5, 2025
Apr 9, 2025BDPT
BIOADAPTIVES, INC.
POpen-market purchase
Option to Purchase Common Stockderivative
+1--1May 5, 2025
Apr 15, 2025BDPT
BIOADAPTIVES, INC.
AGrant or award
Series D Convertible Preferred Stockderivative
+501$9.99$5,00544,940May 5, 2025

Questions about Mark P Frissora

Answered from the filings on this page, as of the latest one.

Is Mark P Frissora buying or selling?

Mark P Frissora has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Mark P Frissora's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark P Frissora has 0.

Where does Mark P Frissora file Form 4?

Mark P Frissora has filed Form 4 at BDPT (BIOADAPTIVES, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.